[ALA] QoQ Quarter Result on 31-Mar-2019 [#Q3]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q3]
Profit Trend
QoQ- -695.86%
YoY- -81.92%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 370 192 396 198 427 427 40 338.86%
PBT -7,699 -3,850 -7,850 -3,925 -435 -435 -2,276 124.84%
Tax 0 0 -925 463 0 0 373 -
NP -7,699 -3,850 -6,925 -3,462 -435 -435 -1,903 153.25%
Tax Rate - - - - - - - -
Total Cost 8,069 4,041 7,321 3,660 862 862 1,944 157.60%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -2,081.94 -2,008.97 -1,748.22 -1,748.22 -101.83 -101.83 -4,716.02 -41.93%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.05 -0.03 -0.04 -0.03 -0.00 -0.00 -0.04 15.99%
EPS Diluted -0.05 -0.03 -0.04 -0.03 -0.00 -0.00 -0.04 15.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.